Mesenchymal stem cell therapy for liver disease: full of chances and challenges
Abstract Liver disease is a major health problem that endangers human health worldwide. Currently, whole organ allograft transplantation is the gold standard for the treatment of end-stage liver disease. A shortage of suitable organs, high costs and surgical complications limit the application of li...
Main Authors: | Xue Yang, Yan Meng, Zhipeng Han, Fei Ye, Lixin Wei, Chen Zong |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-10-01
|
Series: | Cell & Bioscience |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13578-020-00480-6 |
Similar Items
-
Autologous Bone Marrow Mesenchymal Stem Cell Transplantation in Liver of a Patient with Liver Cirrhosis: Case Report
by: Boyukkishi A. Agaev, et al.
Published: (2015-03-01) -
Progress in mesenchymal stem cell–based therapy for acute liver failure
by: Yong-Hong Wang, et al.
Published: (2018-08-01) -
Perspective of placenta derived mesenchymal stem cells in acute liver failure
by: Mahshid Saleh, et al.
Published: (2020-05-01) -
Mesenchymal stem cell therapies for liver cirrhosis: MSCs as “conducting cells” for improvement of liver fibrosis and regeneration
by: Atsunori Tsuchiya, et al.
Published: (2019-09-01) -
A pooled analysis of mesenchymal stem cell-based therapy for liver disease
by: Lu Zhao, et al.
Published: (2018-03-01)